Related Experiment Video
Updated: Jul 2, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children
Weronika Gonciarz1, Lucyna Kozlowska2, Marta Stelmasiak2
1Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Insights
This study identified seven serum metabolites that differ between children infected with Helicobacter pylori (H. pylori) and healthy children. These biomarkers may help monitor H. pylori infection progression and its systemic effects.
Area of Science:
- Metabolomics
- Pediatric Gastroenterology
- Infectious Diseases
Background:
- Helicobacter pylori (H. pylori) infections are linked to gastritis, ulcers, and gastric cancer.
- Monitoring soluble biomarkers offers a way to track H. pylori infection, inflammation, and systemic impact.
Purpose of the Study:
- To analyze serum metabolomic biomarkers in H. pylori-infected children with dyspeptic symptoms.
- To compare these biomarkers against a control group of H. pylori-uninfected healthy children.
Main Methods:
- Serum samples from 32 H. pylori-infected and 32 H. pylori-uninfected children were analyzed.
- Metabolomic profiling was conducted using UPLC-QTOF/MS.
- Volcano plots and ROC analysis identified significant biomarkers.
Main Results:
- Seven serum metabolites were found to differentiate H. pylori-infected from uninfected children.
- These include carboxyethyl lysine, gamma-Glutamylleucine, and hydroxylated arachidonic acid derivatives.
- Identified metabolites relate to immune regulation, metabolism, and oxidative stress.
Conclusions:
- Preliminary findings show distinct metabolite profiles in H. pylori-infected children.
- Further research is needed to validate these biomarkers and their link to H. pylori pathogenesis.
Background:
Infections caused by the Gram-negative bacteria Helicobacter pylori (H. pylori) can result in gastritis, gastric or duodenal ulcers, and gastric cancer in humans. Examining quantitative changes in soluble biomarkers linked to H. pylori infection offers a promising approach to monitor the infection's progression, inflammatory response, and systemic effects.
Aim:
This exploratory study aimed to analyze metabolomic biomarkers in the sera from children with dyspeptic symptoms infected with H. pylori and in control group of healthy children not exposed to H. pylori.
Materials And Methods:
Biological samples: sera from 32 H. pylori-infected children - Hp (+) (female and male) with gastrointestinal symptoms (GIs) under the pediatric gastroenterological medical care; sera from 32 H. pylori uninfected children - Hp(-) (female and male) without GIs under general medical care. The H. pylori status in Hp(+) children was confirmed by 13C urea breath testing, the presence of serum anti-H. pylori IgG antibodies and gastroscopy-based tests (rapid urease test, histological examination of gastric tissue specimens for the presence of Helicobacter-like organisms-HLO and inflammation) while Hp(-) group was selected based on negative result of 13C urea breath test and the lack of serum anti-H. pylori IgG antibodies. Metabolomic profiling was performed using UPLC-QTOF/MS methods. Biomarkers significantly associated with H. pylori infection were identified using volcano plots and ROC analysis.
Results:
This exploratory study found 7 metabolites differentiating the serum samples of Hp(+) from Hp(-) children: carboxyethyl lysine - CEL (HMDB29447), gamma-Glutamylleucine (HMDB0011171), 13-HOTrE(y) hydroxylated and oxidized derivative of the omega-6 fatty acid arachidonic acid (HMDB0341541), 13-HODE (HMDB0004667), lauroylcarnitine (HMDB0002250), vitamin A (HMDB0000305) and 19_norandrosterone (HMDB0002697). These metabolites are associated with immune regulation, energy metabolism, lipid/fatty acid metabolism, lipid peroxidation, oxidative stress, and cell signaling, which may be linked with the pathogenesis of H. pylori infection in humans. However, this hypothesis needs to be confirmed based on direct immune measurements and longitudinal clinical outcomes.
Conclusions:
This exploratory study delivered preliminary results on serum metabolomic profiling indicating differences between metabolites present in serum samples of H. pylori-infected and uninfected children. Further study is required for validation of proposed methodology and connecting the selected metabolites with H. pylori infection.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer